PQ 400
400. Deputy Clare Daly asked the Minister for Health his views on the use by HIQA of Norwegian health technology assessment local data in the absence of validated Irish data on hospitalisation rates for the associated adverse events of the HPV vaccine (details supplied); and if he will make a statement on the matter. [9583/19]
Introduced
26 February 2019
Last action
26 February 2019 · Vaccination Programme
Status
written
Sponsors
Daly, Clare.
Subjects
Discovery layer
Source updated
26 February 2019
Summary
400. Deputy Clare Daly asked the Minister for Health his views on the use by HIQA of Norwegian health technology assessment local data in the absence of validated Irish data on hospitalisation rates for the associated adverse events of the HPV vaccine (details supplied); and if he will make a statement on the matter. [9583/19]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
26 February 2019
Vaccination Programme
400. Deputy Clare Daly asked the Minister for Health his views on the use by HIQA of Norwegian health technology assessment local data in the absence of validated Irish data on hospitalisation rates for the associated adverse events of the HPV vaccine (details supplied); and if he will make a statement on the matter. [9583/19]
Source: written
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Vaccination Programme
Vaccination Programme
xml · EN · 26 February 2019
Sponsors
- Daly, Clare. · Asking member
- Health · Health · Addressed to
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2019-02-26/400/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2019-02-26/pq_400
- ireland · q-2019-02-26-pq_400 · source updated 26 February 2019